
Second primary zzso zzso occurring after zzso treatment have become a major concern during the past zzso Their zzso has long been underestimated because most patients had a short life expectancy after treatment or their follow-up was shorter than 15 zzso With major improvement of long-term survival, longer zzso cancer zzso and zzso programs, it was found that the cumulative zzso of zzso could be as high as zzso of patients treated by zzso This cumulative proportion varies with several factors, which ought to be studied more zzso The delay between zzso and solid tumor emergence is seldom shorter than 10 years and can be as long as half a zzso Thus, inclusion in a cohort of patients with a short follow-up leads to an zzso of the proportion of zzso caused by treatment, unless zzso cumulative zzso is zzso The zzso varies with the tissue and zzso the age of the patient at treatment, zzso factors, but also, and probably zzso with dose distribution, size of the zzso volume, dose, and zzso An effort toward a reduction in their zzso is zzso zzso data suggest that zzso are mainly observed in zzso having absorbed doses above 2 zzso zzso zzso and that their zzso increases with the zzso However, in children zzso and breast zzso are observed following doses as low as 100 zzso and in adults lung zzso have been reported for doses of 500 zzso possibly due to interaction with zzso The dose distribution and the dose per fraction have a major zzso However, the preliminary data regarding these factors need zzso zzso appear to be another important zzso Some data suggest that certain patients, who could be identified, have a high zzso to zzso zzso Efforts should be made to base zzso reduction on solid data and not on speculation or models built on debatable hypotheses regarding the zzso effect zzso In zzso radiation therapy philosophy must evolve, and the aim of treatment should be to deliver the minimal effective radiation therapy rather than the zzso tolerable zzso 

